Companies · Biotechnology

Cal-X Stars Business Accelerator, Inc.

Irvine · Biotechnology

Diligence memoA one-page analyst read on Cal-X Stars Business Accelerator, Inc. — recommendation, valuation, rhythm, risks.
$3.4M
Total raised · real
1
Rounds
1.4×
Latest step-up
Top 65%
Sector rank · raised
Seed
Latest stage · inferred · Mon Nov 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Cal-X Stars Business Accelerator, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.27× the median modeled value of Seed Biotechnology companies in 2013–2015 (122 peers) — value vs value, same stage and era.
  • Issuer reports no revenue, yet is modeled well above niche peers.
Dormant
  • Last raise 12.6 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Cal-X Stars Business Accelerator, Inc. is one of 4293 Biotechnology companies tracked from Irvine. By capital raised it ranks in the long tail (ahead of 36% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(c)
Reg D exemption
147
Investors (latest)
2013-11-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2013-11-18 Raised $1.6M (real) Modeled valuation $69M (est)Seed2013Seed · 2013-11-18 Raised $3.2M (real) Modeled valuation $142M (est)Seed2013Pre-Seed · 2013-11-18 Raised $387K (real) Modeled valuation $21M (est)Pre-Seed2013Pre-Seed · 2013-11-18 Raised $517K (real) Modeled valuation $29M (est)Pre-Seed2013Seed · 2013-11-18 Raised $1.1M (real) Modeled valuation $50M (est)Seed2013Seed · 2013-11-18 Raised $2.4M (real) Modeled valuation $106M (est)Seed2013Seed · 2013-11-18 Raised $3.4M (real) Modeled valuation $151M (est)Seed2013+$3.2M+$387K+$517K+$1.1M+$2.4M+$3.4MCumulative $13M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.6M · 2013
Seed extension$3.2M · 2013
Bridge · Seed-stage$387K · 2013smaller follow-on
Bridge · Seed-stage$517K · 2013smaller follow-on
Seed extension$1.1M · 2013
Seed extension$2.4M · 2013
Seed extension$3.4M · 2013

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$151.4M
Base estimate est.
$2.5M
Conservative case
$1.2B
Upside case
$17.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Seed · modeled $68.9M · 2013-11-182013Seed · modeled $141.9M · 2013-11-18Pre-Seed · modeled $21.4M · 2013-11-18Pre-Seed · modeled $28.5M · 2013-11-18Seed · modeled $50.5M · 2013-11-18Seed · modeled $105.8M · 2013-11-18Seed · modeled $151.4M · 2013-11-182013
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
6.0 yr
Elapsed time used
12.6 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
12.6 yr
On record since
2013
First round
7
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.5× of median
This company$3.4M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage) 2.0× above median
This company$3.4M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 2.4× above median
This company$151.4M
Sector median$64.2M

Raised more than 36% of sector peers (real $). Modeled value above 66% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #10 of 122.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Harpoon Medical, Inc. · Seed Raised $7.8M · modeled $173.2M (est)Admittance Technologies, Inc. · Seed Raised $3.9M · modeled $173.0M (est)Bell Biosystems, Inc. · Seed Raised $6.2M · modeled $169.2M (est)Nexstim Plc · Seed Raised $3.7M · modeled $166.4M (est)Iontera, Inc. · Seed Raised $16.8M · modeled $164.2M (est)Monteris Medical Inc · Seed Raised $9.0M · modeled $163.1M (est)Abzena plc · Seed Raised $4.3M · modeled $160.0M (est)Alkahest, Inc. · Seed Raised $3.5M · modeled $155.4M (est)ONCoPEP, Inc. · Seed Raised $12.7M · modeled $153.5M (est)QT Holdings Corp. · Seed Raised $3.8M · modeled $145.9M (est)Insight Genetics, Inc. · Seed Raised $5.5M · modeled $135.4M (est)Cal-X Stars Business Accelerator, Inc. (this company) Raised $3.4M · modeled $151.4M (est)Cal-X Stars Business Accelerator, Inc.
CompanyStageRaised · realValue · estvs peer med.
Harpoon Medical, Inc.Seed$7.8M$173.2M2.59×
Admittance Technologies, Inc.Seed$3.9M$173.0M2.59×
Bell Biosystems, Inc.Seed$6.2M$169.2M2.53×
Nexstim PlcSeed$3.7M$166.4M2.49×
Iontera, Inc.Seed$16.8M$164.2M2.46×
Monteris Medical IncSeed$9.0M$163.1M2.44×
Abzena plcSeed$4.3M$160.0M2.40×
Alkahest, Inc.Seed$3.5M$155.4M2.33×
ONCoPEP, Inc.Seed$12.7M$153.5M2.30×
Cal-X Stars Business Accelerator, Inc. this companySeed$3.4M$151.4M2.27×
QT Holdings Corp.Seed$3.8M$145.9M2.19×
Insight Genetics, Inc.Seed$5.5M$135.4M2.03×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.6M2013-11-18$7.8M$68.9M90%
Seed$3.2M2013-11-18$16.0M$141.9M90%
Pre-Seed$387K2013-11-18$2.2M$21.4M90%
Pre-Seed$517K2013-11-18$2.9M$28.5M90%
Seed$1.1M2013-11-18$5.7M$50.5M90%
Seed$2.4M2013-11-18$11.9M$105.8M90%
Seed$3.4M2013-11-18$17.0M$151.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.6M2013-11-18
    • First recorded raise — entered as Seed.
    • 49 investors on this round.
  2. Seed$3.2M2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 113 investors on this round.
  3. Pre-Seed$387K2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.3× smaller than the prior — bridge or down round.
    • 18 investors on this round.
  4. Pre-Seed$517K2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 24 investors on this round.
  5. Seed$1.1M2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.2× larger than the prior — scaling up.
    • 36 investors on this round.
  6. Seed$2.4M2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 92 investors on this round.
  7. Seed$3.4M2013-11-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× larger than the prior — scaling up.
    • 147 investors on this round.
Intelligence
Modeled next raise
$4.9M
Modeled next size est.range $3.4M$7.8M
1.4×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Paul Norman3 other2013-11
Howard Leonhardt2 other2013-11
JOHN PAGLIA2 other2013-11
Alex Richardson1 other2013-11
Jeffrey Donofrio1 other2013-11
Ken Evans1 other2013-11
Leslie Miller2013-11
Stuart Richardson2013-11
Registry & provenance

Cal-X Stars Business Accelerator, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1580108
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Second Heart Assist, Inc.BiotechnologySeries B$84.3M$39.7Mnetwork4 shared operators · same sector
Captozyme Inc.BiotechnologySeed$3.4M$151.0Msame sector · same stage
Moleculera Labs, Inc.BiotechnologySeed$3.4M$131.4Msame sector · same stage
Stellar Biotechnologies Inc.BiotechnologySeed$3.4M$123.6Msame sector · same stage
Corino Therapeutics, Inc.BiotechnologySeed$3.5M$154.3Msame sector · same stage
Apostle, Inc.BiotechnologySeed$3.3M$148.0Msame sector · same stage
Heartpoint Global Inc.BiotechnologySeed$3.3M$147.9Msame sector · same stage
Kit Company, Inc.BiotechnologySeed$3.3M$119.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
X-Biomedical Inc.BiotechnologyPre-Seed$23.5M83%
California Cultured Inc.BiotechnologySeries A$48.1M82%
Constellation Pharmaceuticals IncBiotechnologySeries C$2.7B82%
Calviri IncBiotechnologySeries A$3.5M81%
Caladrius Biosciences, Inc.BiotechnologySeries B$777.5M81%
Calysta, Inc.BiotechnologySeries C$1.9B81%
Ascent Industries Corp.BiotechnologyPre-Seed$26.3M81%
TrackX Technology, Inc.BiotechnologySeries A$150.5M81%
Frequently asked
How much funding has Cal-X Stars Business Accelerator, Inc. raised?
Cal-X Stars Business Accelerator, Inc. has raised approximately $3.4M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Cal-X Stars Business Accelerator, Inc.'s estimated valuation?
Provath's modeled valuation for Cal-X Stars Business Accelerator, Inc. is approximately $151.4M (modeled range $2.5M–$1.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Cal-X Stars Business Accelerator, Inc. at?
Cal-X Stars Business Accelerator, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Nov 18.
What does Cal-X Stars Business Accelerator, Inc. do and where is it based?
Cal-X Stars Business Accelerator, Inc. operates in the Biotechnology sector, based in Irvine.
Explore related

See where Cal-X Stars Business Accelerator, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Cal-X Stars Business Accelerator, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.